Security
QCLS · Q/C TECHNOLOGIES, INC.
QCLSNASDAQCommon stockCurrentCIK 1321834Updated Sep 24, 2026
Name history
Q/C TECHNOLOGIES, INC. · through Sep 22, 2026TNF Pharmaceuticals, Inc. · through Sep 10, 2025MyMD Pharmaceuticals, Inc. · through Jul 1, 2024Akers Biosciences, Inc. · through Apr 16, 2021Akers Biosciences Inc · through Apr 11, 2017
QCLS price & chart
Loading TradingView…
NASDAQ:QCLS on TradingView ↗About the company
Q/C Technologies believes the next leap in frontier computing is optical. The Company is pioneering next-generation optical computing solutions designed to harness the properties of light to perform complex computations naturally via interference. Overcoming key challenges posed by electronic GPUs, Q/C Technologies seeks to develop proprietary optical processing units with orders of magnitude faster clock speed and bandwidth and vastly improved energy efficiency relative to traditional computing architectures. qctechnologies.com
In the news
Recent filings
Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 1.01, 5.02, 7.01, 9.01
Termination of a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 1.02, 5.02, 9.01
10-Q filing
Termination of a Material Definitive Agreement · Other Events
Items 1.02, 8.01
10-Q filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 41,166,096Source | 21,421,084Source | 17,862,270Source | 17,539,980Source |
| GoodwillUSD | 10,498,539Source | 10,498,539Source | 10,498,539Source | 10,498,539Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 986,996Source | 173,154Source | 2,681,010Source | 749,090Source |
| Assets, CurrentUSD | 16,580,558Source | 9,411,966Source | 5,816,342Source | 5,401,779Source |
| Operating Lease, Right-of-Use AssetUSD | — | 10,579Source | 47,389Source | 139,662Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 16,441,042Source | 6,701,340Source | 5,088,627Source | 2,844,924Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 184,502Source | 3,364Source | 2,019Source | 108,309,436Source |
| Additional Paid in CapitalUSD | 165,545,382Source | 138,780,138Source | 114,200,096Source | — |
| Retained Earnings (Accumulated Deficit)USD | -144,122,733Source | -129,138,286Source | -101,977,067Source | -93,758,904Source |
| Stockholders' Equity Attributable to ParentUSD | 21,751,675Source | 9,789,740Source | 12,369,572Source | 14,695,056Source |
| Liabilities and EquityUSD | 41,166,096Source | 21,421,084Source | 17,862,270Source | 17,539,980Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,532,042Source | 6,701,340Source | 4,988,089Source | 2,768,983Source |
| Operating Lease, Liability, CurrentUSD | — | 10,579Source | 48,870Source | 65,780Source |
| Accounts Payable, CurrentUSD | 2,445,346Source | 2,902,104Source | 3,716,218Source | 2,673,221Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | 75,941Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 382,994Source | 386,683Source | 637,138Source | 316,666Source |
| Dividends Payable, CurrentUSD | 365,970Source | 2,455,675Source | 265,019Source | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 2,174,524Source | 1,057,271Source | 3,049,537Source | 695,191Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 18,200Source | — | — | — |
| Deferred Income Tax Expense (Benefit)USD | -1,606,119Source | -5,446,000Source | 4,129,000Source | -5,914,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -9,065,619Source | -8,976,347Source | -12,980,625Source | -12,270,068Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -8,424,360Source | -6,101,329Source | 1,845,726Source | 6,913,163Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 18,303,821Source | 12,569,820Source | 13,066,819Source | 5,550,028Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 813,842Source | -2,507,856Source | 1,931,920Source | 193,123Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | 13,322Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 104,506Source | 507,390Source | 1,962,138Source | 338,922Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | 983,000Source | -388,000Source | — | — |
| Dividends Payable, CurrentUSD | 365,970Source | 2,455,675Source | 265,019Source | — |
| General and Administrative ExpenseUSD | 3,736,525Source | 4,161,907Source | 5,442,886Source | 5,520,150Source |
| GoodwillUSD | 10,498,539Source | 10,498,539Source | 10,498,539Source | 10,498,539Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | 0Source | — |
| Impairment of Intangible Assets, Finite-livedUSD | 1,500,000Source | — | — | — |
| Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | -2,176Source | -976Source | — | — |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | 2,176Source | 976Source | — | — |
| Marketable Securities, Unrealized Gain (Loss)USD | 38,671Source | 671Source | 514Source | 2,958Source |
| Net Income (Loss) Attributable to ParentUSD | -11,627,122Source | -23,359,334Source | -3,999,950Source | -15,197,336Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -14,984,446Source | -27,161,219Source | -8,218,163Source | — |
| Nonoperating Income (Expense)USD | -1,779,765Source | -13,190,544Source | 13,123,102Source | 85,427Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | 5,550,028Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | 29,982Source |
| Stock or Unit Option Plan ExpenseUSD | 777,069Source | 73,318Source | 142,565Source | 105,420Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -9,847,357Source | -10,168,790Source | -17,123,052Source | -15,282,763Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -11,627,122Source | -23,359,334Source | -3,999,950Source | -15,197,336Source |
| Net Income (Loss) Attributable to ParentUSD | -11,627,122Source | -23,359,334Source | -3,999,950Source | -15,197,336Source |
| Earnings Per Share, BasicUSD per share | -8.66Source | -11.15Source | -5.33Source | -0.39Source |
| Earnings Per Share, DilutedUSD per share | -8.66Source | -11.15Source | -5.33Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 1,729,946Source | 2,437,000Source | 1,542,453Source | 38,825,763Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 1,729,946Source | 2,437,000Source | 1,542,453Source | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 3,736,525Source | 4,161,907Source | 5,442,886Source | 5,520,150Source |
| Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment LossUSD | 2,176Source | 976Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -14,984,446Source | -27,161,219Source | -8,218,163Source | — |
| Nonoperating Income (Expense)USD | -1,779,765Source | -13,190,544Source | 13,123,102Source | 85,427Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | 3,357,324Source | 3,801,885Source | 4,218,213Source | — |
| Research and Development ExpenseUSD | 3,471,841Source | 3,441,010Source | 7,867,795Source | 9,067,422Source |
Filing attachments
ex99-1.htm · 8-K · 2026-09-18
EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 Q/C Technologies Names Yossef Ehrlichman Chief Technology Officer to Lead Optical Processor Development Proprietary silicon photonic architecture targets critical bandwidth, energy efficiency and scalability demands of AI inference Optical processors aim to cut the energy and bandwidth cost of moving data in AI systems SAN FRANCISCO, September 15, 2026 - Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C Technologies” or “the Company”), a developer o…
Read attachment ↗ex99-1.htm · 8-K · 2026-01-23
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 Q/C Technologies Appoints AI Systems Leader Chelsea Voss to Board of Directors New York, NY, Jan. 20, 2026 (GLOBE NEWSWIRE) - Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C Technologies” or “the Company”), a pioneer of quantum-class computing at the speed of light, today announced the appointment of Chelsea Voss to its Board of Directors. Ms. Voss is a computer scientist and Member of Technical Staff at OpenAI, where she has played a key role in the …
Read attachment ↗ex4-1.htm · 8-K · 2025-12-09
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 FORM OF WARRANT NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT…
Read attachment ↗ex99-1.htm · 8-K · 2025-12-09
EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 Quantum-Class Computing Developer Q/C Technologies Welcomes Strategic Advisor Martin Shkreli New York - December 9, 2025 - Q/C Technologies, Inc. (Nasdaq: QCLS) (“Q/C” or “the Company”), a pioneer of quantum-class computing at the speed of light, today announced that Martin Shkreli become a Strategic Advisor to the Company, contributing his experience in technology, industry contacts, financial innovation and early-stage growth. Q/C Technologies w…
Read attachment ↗ex4-1.htm · 8-K · 2025-10-03
EX-4.1 3 ex4-1.htm EX-4.1 Exhibit 4.1 FORM OF WARRANT NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT…
Read attachment ↗ex99-1.htm · 8-K · 2025-09-26
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS” Licensed technology positions Company at forefront of new quantum-class computing paradigm New York, NY - Q/C Technologies, Inc. (Nasdaq: QCLS), formerly TNF Pharmaceuticals, Inc. (Nasdaq: TNFA), (“Q/C” or “the Company”), today announced that its common stock will begin trading under the new ticker symbol “QCLS” beginning today at the market …
Read attachment ↗